Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

521
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
521
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.4K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.4K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

2.7K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.7K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

6.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Assertive Outreach, Individual Involvement, and Significant Other Involvement on XR-NTX Adherence.

Substance use & addiction journal·2026
Same author

Inconsistent Self-Reports of Lifetime Suicide Attempts During Residential Treatment for Opioid Use Disorder.

Journal of dual diagnosis·2026
Same author

An uncontrolled pilot trial of a buprenorphine dispensing device to enhance outpatient treatment for opioid use disorder.

Heroin addiction and related clinical problems·2026
Same author

Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use Disorder.

Journal of addiction medicine·2026
Same author

Written exposure therapy for post-traumatic stress disorder in residential treatment for substance use disorders: A randomized feasibility trial.

Addictive behaviors·2026
Same author

Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial.

Substance use & misuse·2026
Same journal

Reimagining the Behavioral Health Crisis Care Continuum for Youth.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Addressing the Behavioral Health Needs of Special Populations Within the Youth Crisis Care Continuum.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Technology-Enabled Crisis Care for Youth: Bridging the Gap.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Crisis Phone Services.

Child and adolescent psychiatric clinics of North America·2026
Same journal

A Crisis Care Continuum for Children and Adolescents: The Boston Medical Center Model.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Mobile Response and Stabilization Services.

Child and adolescent psychiatric clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.9K

Opioid Use Disorders.

Bikash Sharma1, Ann Bruner2, Gabrielle Barnett1

  • 1Mountain Manor Treatment Center, Baltimore, MD, USA.

Child and Adolescent Psychiatric Clinics of North America
|June 25, 2016
PubMed
Summary
This summary is machine-generated.

Adolescent opioid addiction is a major crisis. Effective treatment combines medication for opioid use disorder (OUD) with psychosocial support, but access remains limited.

Keywords:
HeroinInjectionOpioid use disorderOpioidsOverdosePrescription opioidsWithdrawal

More Related Videos

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

22.0K
Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.7K

Related Experiment Videos

Last Updated: Mar 19, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.9K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

22.0K
Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.7K

Area of Science:

  • Addiction Medicine
  • Adolescent Health
  • Public Health

Background:

  • Opioid use disorder (OUD) presents a significant public health challenge, particularly among adolescents and young adults.
  • Devastating consequences impact youth and families, necessitating urgent intervention strategies.

Purpose of the Study:

  • To highlight the critical need for enhanced treatment capacity for adolescent opioid addiction.
  • To emphasize the importance of integrating evidence-based treatments for OUD.

Main Methods:

  • Review of current understanding of OUD in adolescents.
  • Analysis of treatment components including emergency overdose management, detoxification, and long-term care.
  • Examination of emerging consensus on pharmacotherapy and psychosocial interventions.

Main Results:

  • Opioid overdose is a life-threatening emergency requiring immediate naloxone administration and respiratory support.
  • Detoxification is a necessary but insufficient step in OUD treatment.
  • Effective OUD treatments exist but face significant limitations in treatment capacity.

Conclusions:

  • Opioid overdose events present a crucial opportunity to initiate addiction treatment.
  • Comprehensive treatment for OUD should incorporate relapse prevention medications like buprenorphine and extended-release naltrexone.
  • Integrating these medications with psychosocial support, including counseling and family involvement, is essential for effective long-term recovery.